手术视频
关于我们
联系我们
中心官网
泌尿系统常见疾病循证医学证据
首页
良性前列腺增生
泌尿系统感染
泌尿系统结石
前列腺炎
前列腺癌
膀胱肿瘤
肾癌
其他
首页
搜索结果
证据分类
良性前列腺增生
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
手术视频
调查问卷
泌尿系统感染
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
泌尿系统结石
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
前列腺炎
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
前列腺癌
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
膀胱肿瘤
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
肾癌
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
其他
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
搜索结果
按关键字
按标题
按关键词
按摘要
按作者
按期刊
共搜索到
5条
与
Practice Guidelines as Topic
有关的结果
Efficacy and Safety of Prostatic Arterial Embolization: Systematic Review with Meta-Analysis and Meta-Regression
2017年 发布于
J Urol
197卷 第2期
Shim
S. R. Kanhai
K. J. Ko
Y. M. Kim
J. H.
Arteries
Embolization
Therapeutic/*adverse effects/methods/standards
Humans
Kallikreins/blood
Lower Urinary Tract Symptoms/blood/etiology/*therapy
Male
Practice Guidelines as Topic
Prostate/blood supply
Prostate-Specific Antigen/blood
Prostatic Hyperplasia/blood/complications/*therapy
Quality of Life
Treatment Outcome
*arteries
*embolization
*investigational
*prostatic hyperplasia
*therapeutic
*therapies
*treatment outcome
文献简介
原文链接
Bladder Cancer, Version 2.2022 Featured Updates to the NCCN Guidelines
2022 年 发布于
Journal of the National Comprehensive Cancer Network
20 卷 第 8 期
Flaig T. W.
Spiess P. E.
Abern M.
Agarwal N.
Bangs R.
Boorjian S. A.
Buyyounouski M. K.
Chan K.
Chang S.
Friedlander T.
Greenberg R. E.
Guru K. A.
Herr H. W.
Hoffman-Censits J.
Kishan A.
Kundu S.
Lele S. M.
Mamtani R.
Margulis V.
Mian O. Y.
Michalski J.
Montgomery J. S.
Nandagopal L.
Pagliaro L. C.
Parikh M.
Patterson A.
Plimack E. R.
Pohar K. S.
Preston M. A.
Richards K.
Sexton W. J.
Siefker-Radtke A. O.
Tollefson M.
Tward J.
Wright J. L.
Dwyer M. A.
Cassara C. J.
Gurski L. A.
Follow-Up Studies
Humans
Medical Oncology
Practice Guidelines as Topic
*Urinary Bladder Neoplasms/diagnosis/therapy
文献简介
原文链接
Is metabolic syndrome associated with high tumor grade and stage of bladder cancer: a systematic review and meta-analysis
2021 年 发布于
Biomedical Journal
12 卷 第 7 期
Feng D.
Song P.
Yang Y.
Wei W.
Li L.
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Carcinoma
Transitional Cell/*drug therapy/pathology
Clinical Trials
Phase II as Topic
Clinical Trials
Phase III as Topic
Humans
Neoplasm Metastasis
Neoplasm Staging
Practice Guidelines as Topic
Randomized Controlled Trials as Topic
Urinary Bladder Neoplasms/*drug therapy/pathology
Immune checkpoint inhibitors
Platinum-based chemotherapy
Survival outcomes
Treatment guidelines
Urothelial carcinoma
funded this work. MK
PK
and SD are employees of Evidera.
文献简介
原文链接
超声造影评估膀胱肿瘤 TNM 分期价值的系统评价
2021 年 发布于
Frontiers in Oncology
34 卷 第 3 期
林莉
傅崇德
李涛
Antineoplastic Agents/*therapeutic use
Chemotherapy
Adjuvant/*statistics & numerical data
*Cystectomy
Global Health
Guideline Adherence/statistics & numerical data
Humans
Models
Statistical
Neoadjuvant Therapy/*statistics & numerical data
Neoplasm Invasiveness
Practice Guidelines as Topic
Practice Patterns
Physicians'/*statistics & numerical data
Urinary Bladder Neoplasms/*drug therapy/pathology/surgery
文献简介
原文链接
Prognostic Role of Platelet-to-Lymphocyte Ratio in Patients With Bladder Cancer: A Meta-Analysis
2019 年 发布于
Actas Urol Esp (Engl Ed)
98 卷 第 5 期
Wang X. M.
Ni X. Y.
Tang G. L.
Clinical Decision-Making
Cystectomy/*methods
Cytoreduction Surgical Procedures/methods
Humans
*Neoplasm Metastasis/pathology/therapy
Practice Guidelines as Topic
Treatment Outcome
*Urinary Bladder Neoplasms/pathology/surgery
Bladder cancer
Lymph node dissection
Lymph node metastasis
Metastasectomy
Metastatic bladder cancer
Surgery
interest
including specific financial interests and relationships and
affiliations relevant to the subject matter or materials discussed in the
manuscript (eg
employment/affiliation
grants or funding
consultancies
honoraria
stock ownership or options
expert testimony
royalties
or patents
filed
received
or pending)
are the following: None.
文献简介
原文链接